Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 3/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 9/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 7/20 | 0.58 |
| ▸ | CYP2D6 | P10635 | 7/20 | 0.58 |
| ▸ | CYP2C19 | P33261 | 7/20 | 0.58 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.58 |
| ▸ | GAA | P10253 | 1/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.56 |
| ▸ | LMNA | P02545 | 5/20 | 0.56 |
| ▸ | MEN1 | O00255 | 4/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.56 |
| ▸ | MAPT | P10636 | 3/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.56 |
| ▸ | CYP11B1 | P15538 | 3/20 | 0.50 |
| ▸ | CYP11B2 | P19099 | 3/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.50 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16382293 | 0.85 | IDO1 (0.73) | IDO1CYP3A4CYP1A2CYP2D6CYP2C19 | |
| SCHEMBL31408101 | 0.85 | IDO1 (0.73) | IDO1CYP3A4CYP1A2CYP2D6CYP2C19 | |
| SCHEMBL11073181 | 0.85 | CYP3A4 (0.54) | IDO1CYP3A4CYP1A2CYP2D6CYP2C19 | |
| SCHEMBL11833225 | 0.81 | IDO1 (0.54) | IDO1CYP3A4CYP1A2CYP2D6CYP2C19 | |
| SCHEMBL8469809 | 0.79 | IDO1 (0.66) | IDO1CYP3A4CYP1A2CYP2D6CYP2C19 | |
| SCHEMBL28287055 | 0.79 | IDO1 (0.66) | IDO1CYP3A4CYP1A2CYP2D6CYP2C19 | |
| SCHEMBL4020890 | 0.79 | CYP1A2 (0.64) | IDO1CYP3A4CYP1A2CYP2D6CYP2C19 | |
| SCHEMBL30745245 | 0.78 | CYP3A4 (0.47) | IDO1CYP3A4CYP1A2CYP2D6CYP2C19 | |
| SCHEMBL28484926 | 0.78 | IDO1 (0.63) | IDO1CYP3A4CYP1A2CYP2D6CYP2C19 | |
| SCHEMBL28493083 | 0.78 | IDO1 (0.63) | IDO1CYP3A4CYP1A2CYP2D6CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117820819-A | Electronic grade weather-resistant epoxy resin composition, and preparation method and application thereof | 安徽美佳新材料股份有限公司 | 2024-04-05 | — | — | CN | claimed |
| CN-114920916-B | Continuous synthesis method of poly (butylene succinate) | 上海师范大学 | 2023-11-28 | — | — | CN | claimed |
| EP-3500562-B1 | SUBSTITUTED AZOLE DERIVATIVES FOR GENERATION, PROLIFERATION AND DIFFERENTIATION OF HEMATOPOIETIC STEM AND PROGENITOR CELLS | NAT UNIV SINGAPORE (SG) | 2023-11-15 | — | — | EP | claimed |
| CN-107207531-A | It is used as the imdazole derivatives of the fusion of TGF beta inhibitors | 里格尔药品股份有限公司 | 2017-09-26 | — | — | CN | claimed |
| CN-101484453-B | Derivatives of imidazo [1, 2-alpha ] pyridine-2-carboxamides, their preparation and their use in therapy | SANOFI AVENTIS | 2012-07-04 | — | — | CN | claimed |
| CN-101484453-A | Derivatives of imidazo [1, 2-alpha ] pyridine-2-carboxamides, their preparation and their use in therapy | SANOFI AVENTIS (FR) | 2009-07-15 | — | — | CN | claimed |
| US-20250382326-A1 | MULTIMODAL ANION EXCHANGE LIGANDS FOR PURIFICATION OF VIRAL PARTICLES AND NUCLEIC ACIDS | BOARD OF TRUSTEES OF THE UNIVERSITY ARKANSA (US) | 2025-12-18 | — | — | US | disclosed |
| US-12442787-B2 | Transition metal electron transfer complex having C—N ligand and electrochemical bio sensor using same | I-SENS, INC. (KR) | 2025-10-14 | — | — | US | disclosed |
| CN-117820819-A | Electronic grade weather-resistant epoxy resin composition, and preparation method and application thereof | 安徽美佳新材料股份有限公司 | 2024-04-05 | — | — | CN | disclosed |
| EP-4329041-A1 | NON-AQUEOUS ELECTROLYTE COMPRISING ADDITIVE FOR NON-AQUEOUS ELECTROLYTE, AND LITHIUM SECONDARY BATTERY COMPRISING SAME | LG Energy Solution, Ltd. (KR) | 2024-02-28 | — | — | EP | disclosed |
| US-20230242531-A1 | Monoacylglycerol Lipase Modulators | JANSSEN PHARMACEUTICA NV (BE) | 2023-08-03 | — | — | US | disclosed |
| US-20230125122-A1 | NOVEL TRANSITION METAL ELECTRON TRANSFER COMPLEX HAVING C-N LIGAND AND ELECTROCHEMICAL BIO SENSOR USING SAME | SOGANG UNIVERSITY RESEARCH & BUSINESS DEVELOPMENT FOUNDATION (KR) | 2023-04-27 | — | — | US | disclosed |
| EP-4131550-A1 | ELECTROLYTE ADDITIVE FOR SECONDARY BATTERY, NON-AQUEOUS ELECTROLYTE COMPRISING SAME FOR LITHIUM SECONDARY BATTERY, AND LITHIUM SECONDARY BATTERY | LG Energy Solution, Ltd. (KR) | 2023-02-08 | — | — | EP | disclosed |
| EP-0627499-B1 | Agent for treating surfaces of copper and copper alloys | SHIKOKU CHEM (JP) | 1997-07-23 | — | — | EP | disclosed |
| US-5560785-A | TREATING SURFACE WITH SOLUTION OF IMIDAZOLE COMPOUND, COPPER COMPOUND, ZINC COMPOUND, STABILIZERS | SHIKOKU CHEMICALS CORPORATION (JP) | 1996-10-01 | — | — | US | disclosed |
| US-5498301-A | ON A PRINTED WIRING BOARD, HEAT RESISTANT, MOISTURE RESISTANT, A 2-ARYLIMIDAZOLE, CARBOXYLIC ACID, AMMONIA, WATER | SHIKOKU CHEMICALS CORPORATION (JP) | 1996-03-12 | — | — | US | disclosed |
| EP-0627499-A1 | Agent for treating surfaces of copper and copper alloys | SHIKOKU CHEMICALS CORPORATION (JP) | 1994-12-07 | — | — | EP | disclosed |
| EP-0003560-B1 | IMIDAZOLE DERIVATIVES AND SALTS THEREOF, THEIR SYNTHESIS, AND PHARMACEUTICAL FORMULATIONS | THE WELLCOME FOUNDATION LIMITED (GB) | 1984-05-02 | — | — | EP | disclosed |
| US-4431815-A | CARDIOTONIC AND ANTISHOCK AGENTS; ANTICOAGULANTS | BURROUGHS WELLCOME CO. (US) | 1984-02-14 | — | — | US | disclosed |
| EP-0003560-A2 | Imidazole derivatives and salts thereof, their synthesis, and pharmaceutical formulations | THE WELLCOME FOUNDATION LIMITED (GB) | 1979-08-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230242531-A1 | Monoacylglycerol Lipase Modulators | MGLL, LPL, PNLIP | IDO1 1745/4885CYP3A4 1831/4885CYP1A2 767/4885 |
| US-20230125122-A1 | NOVEL TRANSITION METAL ELECTRON TRANSFER COMPLEX HAVING C-N LIGAND AND ELECTROCHEMICAL BIO SENSOR USING SAME | MB, CACYBP, SPR | IDO1 4214/4885CYP3A4 2250/4885CYP1A2 3951/4885 |
| US-12442787-B2 | Transition metal electron transfer complex having C—N ligand and electrochemical bio sensor using same | MB, CACYBP, SPR | IDO1 4119/4885CYP3A4 1733/4885CYP1A2 3554/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.